American Journal of Roentgenology, Vol 170, 1005-1013, Copyright © 1998 by American Roentgen Ray Society

ARTICLES

Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium- enhanced gradient-echo images

NL Kelekis, RC Semelka, S Worawattanakul, EE de Lange, SM Ascher, IO Ahn, C Reinhold, EM Remer, JJ Brown, KG Bis, JT Woosley and DG Mitchell
Department of Radiology, University of North Carolina, Chapel Hill 27599-7510, USA.

OBJECTIVE: The purpose of this study was to define the common appearances of hepatocellular carcinoma (HCC) in patients in North America by analyzing T1-weighted, T2-weighted, and serial gadolinium- enhanced gradient-echo images interpreted by radiologists at multiple institutions in North America. MATERIALS AND METHODS: One hundred thirteen consecutive patients with HCC from eight institutions were included in this retrospective case series. Inclusion criteria included MR imaging examinations performed on 1.5-T MR imagers using T1-weighted breath-hold spoiled gradient-echo images, T2-weighted images, and serial gadolinium-enhanced spoiled gradient-echo images. Diagnosis was established by histology in all patients. Images were analyzed retrospectively for lesion count, lesion diameter as less than or equal to 1.5 cm and greater than 1.5 cm, and signal intensity, by individual experienced radiologists at each institution. RESULTS: We found 354 HCC lesions in the 113 patients. Tumors were solitary in 63 patients, multifocal in 45 patients, and diffuse in five patients. Lesion appearance on combined T1-weighted, T2-weighted, and immediate gadolinium-enhanced spoiled gradient-echo images was as follows: 102 lesions (29%) were hypointense on T1-weighted images, were hyperintense on T2-weighted images, and exhibited diffuse heterogeneous enhancement; 52 lesions (15%) were isointense on both T1- and T2-weighted images and exhibited diffuse homogeneous enhancement (all of these lesions measured < or = 1.5 cm in diameter); 50 lesions (14%) were hypointense on T1-weighted images, were hyperintense on T2-weighted images, and exhibited diffuse homogeneous enhancement; 33 lesions (9%) were hypointense on T1-weighted images, were hyperintense on T2-weighted images, and exhibited predominantly peripheral rim enhancement; and 27 lesions (8%) were hypointense on T1-weighted images, were isointense on T2-weighted images, and exhibited diffuse homogeneous enhancement. The remaining 90 lesions showed less common patterns. The appearance of HCCs greater than 1.5 cm and of HCCs less than or equal to 1.5 cm was significantly different (p = .001). The appearance of histologically proven HCCs is separately described. CONCLUSION: The combination of hypointensity on T1-weighted images, hyperintensity on T2-weighted images, and diffuse heterogeneous enhancement was the most common appearance of HCC on MR images in a multiinstitutional patient population in North America. Small HCCs measuring less than or equal to 1.5 cm were frequently isointense on both T1-weighted and T2-weighted images and may be detected on immediate gadolinium-enhanced images only as diffuse homogeneously enhancing lesions.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. H. Choi, J. M. Lee, N. C. Yu, K.-S. Suh, J.-J. Jang, S. H. Kim, and B. I. Choi Hepatocellular Carcinoma in Liver Transplantation Candidates: Detection with Gadobenate Dimeglumine-Enhanced MRI Am. J. Roentgenol., August 1, 2008; 191(2): 529 - 536. [Abstract] [Full Text] [PDF]

				J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]

				F. Hughes-Cassidy, J. Wong, D. Aguirre, A. D. Chavez, T. Wolfson, A. Gamst, and C. Sirlin Transient Homogeneously Enhancing Hepatic Masses: Can Size Predict Benignity? Am. J. Roentgenol., February 1, 2008; 190(2): 300 - 307. [Abstract] [Full Text] [PDF]

				D. Choi, D. G. Mitchell, S. K. Verma, D. Bergin, V. J. Navarro, A. B. Malliah, C. McGowan, H.-W. L. Hann, and S. K. Herrine Hepatocellular Carcinoma with Indeterminate or False-Negative Findings at Initial MR Imaging: Effect on Eligibility for Curative Treatment Initial Observations Radiology, September 1, 2007; 244(3): 776 - 783. [Abstract] [Full Text] [PDF]

				M. Lewin, A. Handra-Luca, L. Arrive, D. Wendum, V. Paradis, E. Bridel, J.-F. Flejou, J. Belghiti, J.-M. Tubiana, and V. Vilgrain Liver Adenomatosis: Classification of MR Imaging Features and Comparison with Pathologic Findings Radiology, November 1, 2006; 241(2): 433 - 440. [Abstract] [Full Text] [PDF]

				E. M. Hecht, A. E. Holland, G. M. Israel, W. Y. Hahn, D. C. Kim, A. B. West, J. S. Babb, B. Taouli, V. S. Lee, and G. A. Krinsky Hepatocellular Carcinoma in the Cirrhotic Liver: Gadolinium-enhanced 3D T1-weighted MR Imaging as a Stand-alone Sequence for Diagnosis. Radiology, May 1, 2006; 239(2): 438 - 447. [Abstract] [Full Text] [PDF]

				A. E. Holland, E. M. Hecht, W. Y. Hahn, D. C. Kim, J. S. Babb, V. S. Lee, A. B. West, and G. A. Krinsky Importance of Small (<=20-mm) Enhancing Lesions Seen Only during the Hepatic Arterial Phase at MR Imaging of the Cirrhotic Liver: Evaluation and Comparison with Whole Explanted Liver Radiology, December 1, 2005; 237(3): 938 - 944. [Abstract] [Full Text] [PDF]

				M. Kanematsu, S. Goshima, H. K. Hussain, T. D. Johnson, H. V. Nghiem, and I. R. Francis Does T2-weighted MR Imaging Really Add No Value in Detection and Characterization of Focal Lesions in Cirrhotic Liver? * Dr Hussain and colleagues respond: Radiology, February 1, 2005; 234(2): 638 - 640. [Full Text]

				H. K. Hussain, I. Syed, H. V. Nghiem, T. D. Johnson, R. C. Carlos, W. J. Weadock, and I. R. Francis T2-weighted MR Imaging in the Assessment of Cirrhotic Liver Radiology, March 1, 2004; 230(3): 637 - 644. [Abstract] [Full Text] [PDF]

				R. C. Carlos, H. M. Kim, H. K. Hussain, I. R. Francis, H. V. Nghiem, and A. M. Fendrick Developing a Prediction Rule to Assess Hepatic Malignancy in Patients with Cirrhosis Am. J. Roentgenol., April 1, 2003; 180(4): 893 - 900. [Abstract] [Full Text] [PDF]

				T. R. Bader, K. L. Beavers, and R. C. Semelka MR Imaging Features of Primary Sclerosing Cholangitis: Patterns of Cirrhosis in Relationship to Clinical Severity of Disease Radiology, March 1, 2003; 226(3): 675 - 685. [Abstract] [Full Text] [PDF]

				H. K. Hussain, F. J. Londy, I. R. Francis, H. V. Nghiem, W. J. Weadock, A. Gebremariam, and T. L. Chenevert Hepatic Arterial Phase MR Imaging with Automated Bolus-Detection Three-dimensional Fast Gradient-Recalled-Echo Sequence: Comparison with Test-Bolus Method Radiology, February 1, 2003; 226(2): 558 - 566. [Abstract] [Full Text] [PDF]

				Y. Y. Jeong, D. G. Mitchell, and T. Kamishima Small (<20 mm) Enhancing Hepatic Nodules Seen on Arterial Phase MR Imaging of the Cirrhotic Liver: Clinical Implications Am. J. Roentgenol., June 1, 2002; 178(6): 1327 - 1334. [Abstract] [Full Text] [PDF]

				G. A. Krinsky, V. S. Lee, N. D. Theise, J. C. Weinreb, N. M. Rofsky, T. Diflo, and L. W. Teperman Hepatocellular Carcinoma and Dysplastic Nodules in Patients with Cirrhosis: Prospective Diagnosis with MR Imaging and Explantation Correlation Radiology, May 1, 2001; 219(2): 445 - 454. [Abstract] [Full Text]

				Y. Itai, T. Irie, and R. C. Semelka Metastatic Liver Tumor: Circumferential versus Wedge-shaped Perilesional Enhancement and Quantitative Image and Pathologic Correlation Dr Semelka responds: Radiology, April 1, 2001; 219(1): 298 - 300. [Full Text]